Conditions:  BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome;  Breast Ductal Carcinoma In Situ;  Hematopoietic and Lymphoid System Neoplasm;  Hereditary Neoplastic Syndrome;  Lynch Syndrome;  Malignant Solid Neoplasm
Interventions:  Procedure: Biospecimen Collection;  Other: Genetic Counseling;  Other: Genetic Testing;  Other: Survey Administration
Sponsors:  OHSU Knight Cancer Institute;  National Cancer Institute (NCI);  Oregon Health and Science University
**RECRUITING NOW**
Interventions:  Procedure: Biospecimen Collection;  Other: Genetic Counseling;  Other: Genetic Testing;  Other: Survey Administration
Sponsors:  OHSU Knight Cancer Institute;  National Cancer Institute (NCI);  Oregon Health and Science University
**RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
